IP Library Granted Patent US 7,033,610
Granted Patent B2
US 7,033,610 · App. 10/193,648 · Granted Apr 25, 2006

Growth-promoting agent

Assignee: Gropep PTY, Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,033,610
App. No.
10/193,648
Granted
Apr 25, 2006
Kind
B2
Abstract

The invention relates to pharmaceutical or veterinary compositions for the treatment of surface wounds; pharmaceutical or veterinary compositions for the treatment of gastrointestinal injuries, diseases or ulcers; methods of treating surface wounds in animals, including humans; and methods for the treatment of gastrointestinal injuries, diseases or ulcers which compositions and methods include compositions of milk product extracts including growth factors with basic to approximately neutral isoelectric points.

Claims (32)

1. A composition for treatment of a surface wound or a gastrointestinal injury, disease, or ulcer, the composition comprising:

a milk product extract composition comprising:

a plurality of basic cell growth stimulating factors from a milk product of a ungulate mammal, the growth stimulating factors:

having basic to approximately neutral isoelectric points,

being enriched with a property of stimulating proliferation of rat myoblasts,

being extracted from milk product in concentrated form, and

comprising less than about 20 wt-% of milk protein present in the milk product; and

a pharmaceutically or veterinarily acceptable diluent, carrier, or excipient.

2. The composition according to claim 1 , comprising saline solution.

3. The composition according to claim 1 , wherein said pharmaceutically or veterinarily acceptable diluent, carrier, or excipient comprises saline solution.

4. The composition according to claim 1 further comprising an effective amount of antibiotic, antiseptic, anesthetic, or mixture thereof.

5. The composition according to claim 1 , wherein said milk product comprises cheese whey.

6. A method for preparing a milk product extract composition;

the composition comprising a plurality of basic cell growth stimulating factors from a milk product of a ungulate mammal, the growth stimulating factors:

having basic to approximately neutral isoelectric points,

being enriched with a property of stimulating proliferation of rat myoblasts,

being extracted from milk product in concentrated form,

comprising less than about 20 wt-% of milk protein present in the milk product;

the milk product extract being prepared by:

providing a source of milk product;

selecting a cationic exchange resin:

suitable for selectively adsorbing a plurality of basic cell growth stimulating factors enriched with a property of stimulating proliferation of rat myoblasts,

such that the more basic components of the milk product are adsorbed thereon, and

wherein the major proteins with acidic isoelectric points in the milk products are not adsorbed;

equilibrating said cationic exchange resin with an equilibration buffer;

applying the filtrate to the equilibrated cation exchange resin;

eluting the cationic exchange resin with a high ionic strength buffer solution suitable for such eluting; and

concentrating the milk product extract to obtain a milk protein extract enriched in growth promoting activity and stimulating proliferation of rat myoblasts.

7. The method according to claim 6 , wherein said milk product comprises cheese whey.

8. The method according to claim 6 , wherein the cation exchange resin comprises an agarose-based resin.

9. The method according to claim 6 , wherein the equilibration buffer comprises 1M NaCl containing 0.25M NH 4 OH or 0.4 NaCl added to 10 mM sodium citrate at pH 6.5.

10. The method according to claim 6 , wherein concentrating comprises ultrafiltration using a 3 kD excluding membrane.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2010
From: NOVOZYMES BIOPHARMA AU LIMITED
To: NOVOZYMES BIOPHARMA DK A/S
Reel/Frame 025436/0584 →
CHANGE OF NAME Recorded Aug 19, 2008
From: NOVOZYMES GROPEP LIMITED
To: NOVOZYMES BIOPHARMA AU LIMITED
Reel/Frame 021398/0773 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 021301, FRAME 0075 Recorded Aug 4, 2008
From: GROPEP LIMITED
To: NOVOZYMES GROPEP LIMITED
Reel/Frame 021339/0561 →
CHANGE OF NAME Recorded Jul 25, 2008
From: GROPEP LIMITED
To: NOVOZYMES GROPEP LIMITED
Reel/Frame 021301/0075 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATES PROVIDED ON A DOCUMENT PREVIOUSLY RECORDED AT REEL 015387 FRAME 0694. Recorded Dec 16, 2004
From: BALLARD, FRANCIS JOHN; FRANCIS, GEOFFREY LEONARD; REGESTER, GEOFFREY OWEN; READ, LEANNA CHRISTINE; BELFORD, DAVID ANDREW
To: GROPEP PTY, LTD.
Reel/Frame 015470/0363 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2004
From: BALLARD, FRANCIS JOHN; FRANCIS, GEOFFREY LEONARD; REGESTER, GEOFFREY OWEN; READ, LEANNA CHRISTINE; BELFORD, DAVID ANDREW
To: GROPEP PTY, LTD.
Reel/Frame 015387/0694 →
Priority Claims (2)
AU PK1170 · Jul 13, 1990 · national
AU PN2712 · May 2, 1995 · national
Continuity (5)
Continuation In Part 0991204000 · Jul 24, 2001
Continuation In Part 0881483300 · Mar 11, 1997
Division 0864175400 · May 2, 1996
Continuation In Part 0795675900
Related Publication 20030059477A1 · Mar 27, 2003